Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
US6908613B2 · kind B2 · utility
9Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2001 |
| Grant date | Jun 21, 2005 |
| Priority date | — |
| Expiry date | Jun 8, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20023
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are chimeric HPV L1 proteins and virus like particles comprising the same which are capable of generating high titer neutralizing antibody responses against at least two HPV types. The disclosed chimeric HPV L1 proteins and VLPs are useful as therapeutic and prophylactic reagents, as well as reagents for diagnosing papillomavirus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.